Annelien Bredenoord is a professor of Ethics of Biomedical Innovation at the University Medical Center Utrecht. Her research, consultancy and teaching is focused on the ethical issues in emerging biomedical technology and translational medicine. She is particularly fascinated by the rapid developments in genetics/genomics, regenerative medicine, stem cell research, biobanking, surgical innovation, Big Data and the associated ethical and societal challenges: how to translate biomedical innovations from basic research into clinical care and society in an ethically sound way?
She published widely in those fields and is member of several (inter)national committees among which the Ethics Committee of the International Society for Stem Cell Research (ISSCR), The Young Academy of the Royal Netherlands Academy of Arts and Sciences (KNAW), The Young Health Council, The National Indication Committee Preimplantation Genetic Diagnosis, The NIAS Lorenz Advisory Board, L 'Oreal UNESCO For Women in Science program, and UMC Utrecht’s Research Ethics Committee (METC).
Safarlou CW, Bredenoord AL, Vermeulen R, Jongsma KR.
Am J Bioeth. 2021 Dec;21(12):73-75.
Exposome-NL is a Dutch consortium of over fifty scientists from different disciplines, universities and medical centres. Together the scientists will systematically sequence the environmental factors influencing our health.Read More